Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 20

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

526

HTML

5409

Tables (1-3)

246

Sum=6181

May 28, 2009 (publication date) through Nov 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Articles

World J Gastroenterol. May 28, 2009; 15(20): 2506-2511
Published online May 28, 2009. doi: 10.3748/wjg.15.2506

Table 3 Antidiabetic therapy in HCC, cirrhotic patients and in Controls with type 2 diabetes mellitus n (%)

^a,dvs^b,eP = 0.04; ^a,dvs^c,fP < 0.001; ^b,evs^c,fP < 0.001;

^gvs

^hP < 0.025;

ⁱvs^hP = 0.007.

Citation: Donadon V, Balbi M, Ghersetti M, Grazioli S, Perciaccante A, Della Valentina G, Gardenal R, Dal Mas M, Casarin P, Zanette G, Miranda C. Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease. World J Gastroenterol 2009; 15(20): 2506-2511
URL: https://www.wjgnet.com/1007-9327/full/v15/i20/2506.htm
DOI: https://dx.doi.org/10.3748/wjg.15.2506